Cited by 1,063Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Open access

Vilar, Eduardo, Gruber, Stephen B.·2010·Nature Reviews Clinical Oncology

DOI 10.1038/nrclinonc.2009.237PMC PMC3427139

Open this paper in CoChat — free account

Abstract

Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2. Methods to detect MSI are well established and routinely incorporated into clinical practice. A clinical and molecular profile of MSI tumors has been described, leading to the concept of an MSI phenotype in CRC. Studies have confirmed that MSI tumors have a better prognosis than microsatellite stable CRC, but MSI cancers do not necessarily have the same response to the chemotherapeutic strategies used to treat microsatellite stable tumors. Specifically, stage II MSI tumors might not benefit from 5-fluorouracil-based adjuvant chemotherapy regimens. New data suggest possible advantages of irinotecan-based regimens, but these findings require further clarification. Characterization of the molecular basis of MSI in CRC is underway and initial results show that mutations in genes encoding kinases and candidate genes with microsatellite tracts are over-represented in MSI tumors. Transcriptome expression profiles of MSI tumors and systems biology approaches are providing the opportunity to develop targeted therapeutics for MSI CRC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrclinonc.2009.237

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G. D., & Schaid, D. J. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,131
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876

Show all 100 references

Sorted by citations

Items 501–600 of 1,000

Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression
Li, L., Jiang, D., Liu, H., Guo, C., Zhang, Q., Li, X., Chen, X., Chen, Z., Feng, J., Tan, S., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1878 · Cited by 11
Combining gut microbiota modulation and immunotherapy: A promising approach for treating microsatellite stable colorectal cancer
Chang, Y., Long, M., Shan, H., Liu, L., Zhong, S., & Luo, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104629 · Cited by 12
Perioperative chemotherapy for gastric cancer patients with microsatellite instability or deficient mismatch repair: A systematic review and meta‐analysis
Liu, B., Shen, C., Yin, X., Jiang, T., Han, Y., Yuan, R., Yin, Y., Cai, Z., & Zhang, B. (2025) · Cancer · doi:10.1002/cncr.35831 · Cited by 11
The oncogenic role of treacle ribosome biogenesis factor 1 (TCOF1) in human tumors: a pan-cancer analysis
Gu, W., Sun, L., Wang, J., & Chen, X. (2022) · Aging · doi:10.18632/aging.203852 · Cited by 11
Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
Bu, F., Li, X., Zhao, Y., Bai, L., Zhang, S., & Min, L. (2023) · Biomarker Research · doi:10.1186/s40364-022-00446-5 · Cited by 11
MCM5 is an oncogene of colon adenocarcinoma and promotes progression through cell cycle control
Mao, J., Shen, J. F., Lu, X., Cai, Y., Tao, R., Deng, Y., Zhang, Y., Wu, Y. K., & Chen, W. (2023) · Acta Histochemica · doi:10.1016/j.acthis.2023.152072 · Cited by 12
Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer
Yu, H., Bai, K., Cheng, Y., Lv, J., Song, Q., Yang, H., Lü, Q., & Yang, X. F. (2023) · Aging · doi:10.18632/aging.204853 · Cited by 11
Prognosis and immunotherapy efficacy in dMMR&MSS colorectal cancer patients and an MSI status predicting model
Fu, X., Huang, J., Junling, Z., Fan, X., Wang, C., Deng, W., Tan, X., Chen, Z., Cai, Y., Lin, H., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34946 · Cited by 11
Real‐world treatment patterns and outcomes in refractory metastatic colorectal cancer
Chiang, C., Choi, C., Lam, K. O., Chan, B., Lee, S. F., Yeung, S., Lau, K. S., Chan, S. Y., Choy, T. S., & Yuen, K.-K. (2019) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13114 · Cited by 11
Role of FUT8 expression in clinicopathology and patient survival for various malignant tumor types: a systematic review and meta-analysis
Ma, M., Han, G., Wang, Y., Zhao, Z., Guan, F., & Li, X. (2020) · Aging · doi:10.18632/aging.202239 · Cited by 11
Common fragile sites in colon cancer cell lines: Role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1
Vernole, P., Muzi, A., Volpi, A., Terrinoni, A., Dorio, A. S., Tentori, L., Shah, G. M., & Graziani, G. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.04.006 · Cited by 11
Microsatellite instability in Costa Rican patients with colorectal adenocarcinoma and its association with overall survival and response to fluoropyrimidine-based chemotherapy
Ramos-Esquivel, A., Rodriguez-Porras, L., & Juan, P. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101680 · Cited by 11
The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk
Yang, Y., Zhang, G., Hu, C., Luo, W., Jiang, H., Liu, S., & Yang, H. (2022) · BMC Urology · doi:10.1186/s12894-022-01141-1 · Cited by 10
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
Nowak, M., Jabbar, F., Rodewald, A., Gneo, L., Tomasevic, T., Harkin, A., Iveson, T. J., Saunders, M. P., Kerr, R. S., Oein, K., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101727 · Cited by 10
An integrative pan-cancer analysis of MASP1 and the potential clinical implications for the tumor immune microenvironment
Yu, H., Wang, C., Ke, S., Xu, Y., Lu, S., Feng, Z., Bai, M., Qian, B., Xu, Y., Li, Z., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135834 · Cited by 10
Single-cell and bulk transcriptome analyses reveal elevated amino acid metabolism promoting tumor-directed immune evasion in colorectal cancer
Sun, T.-Y., Chen, Y., & Chen, Y.-X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575829 · Cited by 10
Colorectal Cancer
Lawler, M., Johnston, B., Schaeybroeck, S. V., Salto‐Tellez, M., Wilson, R. H., Dunlop, M. G., & Johnston, P. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00074-8 · Cited by 10
Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer
Qiu, P., Chen, X., Xiao, C., Zhang, M., Wang, H., Wang, C., Li, D., Liu, J., Chen, Y., Liu, L., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04626-0 · Cited by 10
Efficacy and safety of preoperative immunotherapy in patients with mismatch repair-deficient or microsatellite instability-high gastrointestinal malignancies
Li, Y., Liu, X.-Z., Yao, Y., Chen, N., Li, Z., Zhang, X.-Y., Lin, X., & Wu, A. (2023) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v15.i2.222 · Cited by 10
KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China
Lian, S., Tan, L.-X., Liu, X.-Z., Yang, L., Li, N.-N., Feng, Q., Wang, P., Wang, Y., Qiao, D., Zhou, L., et al. (2023) · Medicine · doi:10.1097/md.0000000000033115 · Cited by 10
Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study
Kamat, N., Khidhir, M. A., Alashari, M., & Rannug, U. (2013) · Oncology Letters · doi:10.3892/ol.2013.1573 · Cited by 10
Personalized Adjuvant Treatment of Colon Cancer
Taghizadeh, H., & Prager, G. W. (2020) · Visceral Medicine · doi:10.1159/000508175 · Cited by 10
MC1R Is a Prognostic Marker and Its Expression Is Correlated with MSI in Colorectal Cancer
Peng, L., Chang, J., Liu, X., Lu, S., Ren, H., Zhou, X., Liu, Z., & Hu, P. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030108 · Cited by 10
Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer
Li, T., Liu, W., Chun, W., Wang, M., Hui, W., Lu, J., & Gao, F. (2022) · Journal of Immunology Research · doi:10.1155/2022/5164265 · Cited by 10
The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma
Su, J., Tian, X., Xu, W., Anwaier, A., Ye, S., Zhu, S., Wang, Y., Gu, J., Shi, G., Qu, Y., et al. (2022) · Cancers · doi:10.3390/cancers14204992 · Cited by 10
SH2D4A promotes centrosome maturation to support spindle microtubule formation and mitotic progression
Yuki, R., Ikeda, Y., Yasutake, R., Saito, Y., & Nakayama, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-29362-w · Cited by 10
Molecular Analysis of Iranian Colorectal Cancer Patients at Risk for Lynch Syndrome: a New Molecular, Clinicopathological Feature
Zeinalian, M., Emami, M. H., Salehi, R., Naimi, A., Kazemi, M., & Chaleshtori, M. H. (2015) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-015-9696-1 · Cited by 10
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells
Bommi, P. V., Bowen, C. M., Reyes-Uribe, L., Wu, W., Katayama, H., Rocha, P., Parra, E. R., Francisco-Cruz, A., Ozcan, Z., Tosti, E., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2896 · Cited by 10
Self-citation
Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy
Ye, B.-J., Li, D.-F., Li, X., Hao, J.-L., Liu, D.-J., Yu, H., & Zhang, C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217010 · Cited by 9
DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development
Subbarayan, R., Srinivasan, D., Balakrishnan, R., Kumar, A., Usmani, S. S., & Srivastava, N. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.05.001 · Cited by 9
ABALON regulates mitophagy and 5-FU sensitivity in colorectal cancer via PINK1-Parkin pathway
Liu, H., Huang, Y. K., Zhao, C., Wang, G., & Wang, X. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-933 · Cited by 9
Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma
Brezden‐Masley, C., Fiset, P., Cheung, C. C., Arnason, T., Bateman, J., Borduas, M., Evaristo, G., Ionescu, D. N., Lim, H. J., Sheffield, B. S., et al. (2024) · Current Oncology · doi:10.3390/curroncol31120572 · Cited by 9
Interpretable radiomics model based on dual-layer spectral CT iodine maps for predicting microsatellite instability in colorectal cancer: A two-center study
Chen, W., Jia, Z., Wan, L., Yuan, W., Xu, J., Du, X., Wu, Y., Liu, X., Liu, X., & Wen, Z. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112357 · Cited by 9
Prognosticators of Long‐Term Outcomes of TNM Stage II Colorectal Cancer: Molecular Patterns or Clinicopathological Features
Kuan, T., Chang, S., Lin, J., Lin, T., Yang, S., Jiang, J., Chen, W., Wang, H., Lan, Y., Lin, C., et al. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05158-w · Cited by 9
Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome
Abidi, A., Gorris, M. A. J., Brennan, E., Jongmans, M. C. J., Weijers, D., Kuiper, R. P., de Voer, R. M., Hoogerbrugge, N., Schreibelt, G., & de Vries, I. J. M. (2021) · Cancers · doi:10.3390/cancers13102345 · Cited by 11
The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice
Mohindroo, C., Jesus‐Acosta, A. D., Yurgelun, M. B. B., Maitra, A., Mork, M. E., & McAllister, F. M. (2022) · Surgical pathology clinics · doi:10.1016/j.path.2022.05.004 · Cited by 9
Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer
Ding, Y., Wang, Z., Zhou, F.-M., Chen, C., & Qin, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.987302 · Cited by 9
Prognostic significance of negative lymph node count in microsatellite instability-high colorectal cancer
Dai, X., Dai, Z., Fu, J., Liang, Z., Du, P., & Wu, T. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03469-4 · Cited by 9
Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer
Chen, H., Chen, Q., Chen, J., Mao, Y., Duan, L., Ye, D., Cheng, W., Chen, J., Gao, X., Lin, R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158096 · Cited by 10
Immunoprevention Strategies for Colorectal Cancer in Lynch Syndrome Carriers
Bowen, C. M., Sinha, K. M., & Vilar, E. (2024) · The Cancer Journal · doi:10.1097/ppo.0000000000000738 · Cited by 9
Self-citation
Development of Novel Targeted Agents in the Treatment of Metastatic Colorectal Cancer
Berge, E. M., Thompson, C., & Messersmith, W. A. (2011) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.06.011 · Cited by 9
Mutanome and expression of immune response genes in microsatellite stable colon cancer
Pamplona, R. S., Gil-Hoyos, R., López‐Doriga, A., Alonso, M. H., Aussó, S., Mollevı́, D. G., Santos, C., Sanjuán, X., Salazar, R., Alemany, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7293 · Cited by 9
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
Jongeneel, G., Greuter, M. J. E., van Erning, F. N., Koopman, M., Medema, J. P., Kandimalla, R., Goel, A., Bujanda, L., Meijer, G. A., Fijneman, R. J. A., et al. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01199-4 · Cited by 9
The Role of DNA Repair in Genomic Instability of Multiple Myeloma
Ali, J. Y. H., Fitieh, A. M., & Ismail, I. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105688 · Cited by 11
Cancer predisposition syndromes associated with myeloid malignancy
Quinn, E. A., & Nichols, K. E. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2017.04.003 · Cited by 9
Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix
Zhang, Y., Zulfiqar, M., Bluth, M. H., Bhalla, A., & Beydoun, R. (2018) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2018.03.002 · Cited by 9
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
Yorita, N., Yuge, R., Takigawa, H., Ono, A., Kuwai, T., Kuraoka, K., Kitadai, Y., Tanaka, S., & Chayama, K. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.041 · Cited by 9
Molecular Analysis of Colorectal Cancers Suggests a High Frequency of Lynch Syndrome in Indonesia
Susanti, S., Wibowo, S. H. B., Akbariani, G., Yoshuantari, N., Heriyanto, D. S., Ridwanuloh, A. M., Hariyatun, H., Handaya, A. Y., Kurnianda, J., Hutajulu, S. H., et al. (2021) · Cancers · doi:10.3390/cancers13246245 · Cited by 9
TNM staging system of colorectal carcinoma: surgical pathology of the seventh edition
Puppa, G. (2011) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2011.03.006 · Cited by 9
SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer
Yu, J., Yu, S., Bai, J., Zhu, Z., Gao, Y., & Li, Y. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00758-8 · Cited by 8
Performance assessment of computational tools to detect microsatellite instability
Anthony, H., & Seoighe, C. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae390 · Cited by 8
A comprehensive pan-cancer examination of transcription factor MAFF: Oncogenic potential, prognostic relevance, and immune landscape dynamics
Cai, F., Mao, S., Peng, S., Wang, Z., Li, W., Zhang, R., Zhang, S., Sun, A., & Zhang, S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114105 · Cited by 8
The role of MLH1, MSH2 and MSH6 in the development of colorectal cancer in Uganda
Wismayer, R., Matthews, R., Whalley, C., Kiwanuka, J. P., Kakembo, F. E., Thorn, S., Wabinga, H., Odida, M., & Tomlinson, I. P. M. (2025) · BMC Cancer · doi:10.1186/s12885-025-14195-9 · Cited by 8
Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer
Zhu, Y., Zhou, T., Zheng, Y., Yao, Y., Lin, M., Zeng, C., Yan, Y., Zhou, Y., Li, D.-D., & Zhang, J. (2025) · Genes and Immunity · doi:10.1038/s41435-025-00342-6 · Cited by 8
Emerging strategies in colorectal cancer immunotherapy: enhancing efficacy and survival
Zhang, Y., Guan, H., Feng, X., Liu, M., Shao, J., Liu, M., He, J., Jin, Y., Zhu, J., & Zheng, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1616414 · Cited by 8
Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes
Hirano, D., Urabe, Y., Tanaka, S., Nakamura, K., Ninomiya, Y., Yuge, R., Hayashi, R., Oka, S., Kitadai, Y., Shimamoto, F., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211477 · Cited by 8
High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
Nugteren, S., den Uil, S. H., Diemen, P. M. D., Simons-Oosterhuis, Y., Lindenbergh-Kortleve, D. J., van Haaften, D. H., Stockmann, H. B. A. C., Sanders, J., Meijer, G. A., Fijneman, R. J. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16427-5 · Cited by 8
Prognostic modelling of colorectal cancer based on oxidative stress-related genes
Wu, X., Zhu, Z., & Gai, M.-H. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04914-9 · Cited by 8
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice
Ascrizzi, S., Arillotta, G. M., Grillone, K., Caridà, G., Signorelli, S., Ali, A., Romeo, C., Tassone, P., & Tagliaferri, P. (2023) · Cancers · doi:10.3390/cancers15153930 · Cited by 8
The prognostic and immunological role of FKBP1A in an integrated muti-omics cancers analysis, especially lung cancer
Zhang, Y., Xu, H., Pi, S., Tan, H., Huang, B., & Chen, Y. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05362-1 · Cited by 8
Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants
Sèlves, J., Gloria, H. D. C. E., Brunac, A., Saffi, J., Guimbaud, R., Brousset, P., & Hoffmann, J. (2023) · Life Science Alliance · doi:10.26508/lsa.202302290 · Cited by 8
Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I–III colorectal cancer
Wang, W., Wang, R., Han, X., Zhang, W., Zhu, L., & Gu, Y. (2024) · Medicine · doi:10.1097/md.0000000000037693 · Cited by 8
Towards a precision approach to anesthetic/analgesic immunomodulation in cancer
Gupta, H. V., Tan, K. S., Fischer, G. W., & Mincer, J. S. (2024) · Frontiers in Anesthesiology · doi:10.3389/fanes.2024.1464004 · Cited by 8
Relationship of mismatch repair proteins and survivin in colon polyps and carcinomas
Adamkov, M., Furjelová, M., Horáček, J., Bencat, M., & Kružliak, P. (2014) · Acta Histochemica · doi:10.1016/j.acthis.2014.04.005 · Cited by 8
Tumor microsatellite instability and clinicopathologic features in Iranian colorectal cancer patients at risk for Lynch syndrome.
Zeinalian, M., Chaleshtori, M. H., Salehi, R., Kazemi, M., & Emami, M. H. (2015) · PubMed Central · Cited by 8
The Tendency of Having MSH2 and MSH6 Microsatellite Instability among Clinicopathological Features in Patients with Colorectal Cancer
Arshita, N., Lestari, R. V., Hutajulu, S. H., Ghozali, A., & Paramita, D. K. (2018) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2018.19.11.3147 · Cited by 8
Pancreatic cancer ‘mismatch’ in Lynch syndrome
Hendifar, A. E., Larson, B. K., Rojansky, R. B., Guan, M., Gong, J., Placencio, V. R., Tuli, R., & Hitchins, M. P. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000274 · Cited by 8
Clinical case of the neoadjuvant treatment with nivolumab in a patient with microsatellite unstable (MSI-H) locally advanced gastric cancer
Chubenko, V. A., Inusilaev, G., Имянитов, Е. Н., & Moiseyenko, V. M. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236144 · Cited by 8
The Establishment and Experimental Verification of an lncRNA-Derived CD8+ T Cell Infiltration ceRNA Network in Colorectal Cancer
Wu, Q., Zhang, Z., Ji, M., Yan, T., Jiang, Y., Chen, Y., Jiang, C., Zhang, J., Tang, D., Zhu, D., et al. (2022) · Clinical Medicine Insights Oncology · doi:10.1177/11795549221092218 · Cited by 8
Single‐cell dissection reveals the role of DNA damage response patterns in tumor microenvironment components contributing to colorectal cancer progression and immunotherapy
Shen, X., Mo, S., Wang, Y., Lin, L., Liu, Y., Weng, M., Gu, W., & Nakajima, T. (2023) · Genes to Cells · doi:10.1111/gtc.13017 · Cited by 8
Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?
Jansen, M., Menko, F. H., Brosens, L. A. A., Giardiello, F. M., & Offerhaus, G. J. A. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.07.049 · Cited by 8
Systemic treatment for hereditary cancers: a 2012 update
Имянитов, Е. Н., & Byrski, T. (2013) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-11-2 · Cited by 8
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives
Battaglin, F., Puccini, A., Naseem, M., Schirripa, M., Berger, M. D., Tokunaga, R., McSkane, M., Khoukaz, T., Soni, S., Zhang, W., et al. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.04 · Cited by 8
Correlation between microsatellite instability and RAS gene mutation and stage Ⅲ colorectal cancer
Niu, W., Wang, G., Feng, J., Li, Z., Li, C., & Shan, B. (2018) · Oncology Letters · doi:10.3892/ol.2018.9611 · Cited by 8
Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting
Clarke, E. V., Muessig, K. R., Zepp, J. M., Hunter, J. E., Syngal, S., Acheson, L. S., Wiesner, G. L., Peterson, S. K., Bergen, K. M., Shuster, E., et al. (2019) · Familial Cancer · doi:10.1007/s10689-019-00123-x · Cited by 8
Investigation of an Alternative Marker for Hypermutability Evaluation in Different Tumors
Chen, A., Zhang, S., Xiong, L., Xi, S., Tao, R., Chen, C., Li, J., Chen, J., & Li, C. (2021) · Genes · doi:10.3390/genes12020197 · Cited by 8
Novel Mutations inMLH1andMSH2Genes in Mexican Patients with Lynch Syndrome
Moreno-Ortíz, J. M., Ayala‐Madrigal, M. D. L. L., Corona‐Rivera, J. R., Centeno-Flores, M., Maciel-Gutiérrez, V., Franco‐Topete, R. A., Armendáriz‐Borunda, J., Hotchkiss, E. C., Pérez–Carbonell, L., Rhees, J., et al. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/5278024 · Cited by 8
Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma
Qu, X., Zhao, L., Zhang, R., Wei, Q., & Wang, M. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.54 · Cited by 8
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
Jongeneel, G., Greuter, M. J. E., van Erning, F. N., Koopman, M., Vink, G. R., Punt, C. J. A., & Coupé, V. M. H. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284821995715 · Cited by 8
Multigene Assays to Improve Assessment of Recurrence Risk and Benefit From Chemotherapy in Early-Stage Colon Cancer: Has the Time Finally Arrived, or Are We Still Stage Locked?
Tabernero, J. M., & Baselga, J. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0806 · Cited by 8
A novel quantitative trait locus implicates Msh3 in the propensity for genome-wide short tandem repeat expansions in micePreprint
Maksimov, M. O., Wu, C., Ashbrook, D. G., Villani, F., Colonna, V., Mousavi, N., Ma, N., Lu, L., Pritchard, J. K., Goren, A., et al. (2023) · Genome Research · doi:10.1101/gr.277576.122 · Cited by 9
Detecting microsatellite instability in cancer via multiplexed orthogonal gap-enhanced Raman tags
Fu, G., Li, J., Zhang, Q., Lv, C., Zhang, Z., Wang, X., Wu, R., & Chen, L. (2025) · Chemical Science · doi:10.1039/d5sc01912e · Cited by 7
Fusobacterium nucleatum downregulated MLH1 expression in colorectal cancer by activating autophagy-lysosome pathway
Ding, T., Wu, M., Zhao, L., Liu, H., Cao, X., Guo, J., Zhu, X., Zhao, L., Zhang, H., Gao, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1586146 · Cited by 7
Predictive value of [18F]FDG PET-derived parameters for microsatellite instability and prognosis in patients with colorectal cancer
Guo, W., Jiang, H., Wang, C., Wang, Y., Wang, M., Yang, X., Zhao, Y., Jiang, Z., Nanding, A., Cheng, L., et al. (2025) · European Radiology · doi:10.1007/s00330-025-11732-9 · Cited by 7
Certain pMMR colorectal cancer patients should undergo additional MSI-PCR testing to reduce the risk of misdiagnosing MSI-H and Lynch syndrome
Huang, J., Xu, L., Cai, Y., Tan, X., Lin, H., Chen, Z., Wang, C., Deng, W., & Fu, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-14484-3 · Cited by 7
Precision Oncology Through Dialogue: AI-HOPE-RTK-RAS Integrates Clinical and Genomic Insights into RTK-RAS Alterations in Colorectal Cancer
Yang, E.-W., Waldrup, B., & Velazquez-Villarreal, E. I. (2025) · Biomedicines · doi:10.3390/biomedicines13081835 · Cited by 7
Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study
Li, C., Cai, P., Zeng, H., Li, J., Hu, H., Zhang, J., Wu, Z., Qin, G., & Deng, Y. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s538018 · Cited by 7
Clinical Actionability of Genes in Gastrointestinal Tumors
Gonzalez, N. S., Patelli, G., & Crisafulli, G. (2025) · Genes · doi:10.3390/genes16101130 · Cited by 7
Current advances in colorectal cancer treatment: a review of recent clinical trials
Piotrowski, M., Suska, K., Jacenik, D., & Fichna, J. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2608867 · Cited by 7
Comparative genomic signatures in young and old Chinese patients with colorectal cancer
Wang, F., Cheng, H., Zhang, X., Shan, L., Bai, B., Chen, K., Lou, F., Cao, S., Wang, H., & Dai, S. (2021) · Cancer Medicine · doi:10.1002/cam4.3987 · Cited by 7
MAN2A1 predicts prognosis and progression through cancer-related pathways in colorectal cancer
Wang, Y., Zhao, J., Fu, G., Sheng, C., Zhu, J. X., Zhong, T., Yang, F., & Jiang, Z. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-629 · Cited by 7
Prognosis of mucinous colon cancer is determined by histological biomarkers rather than microsatellite instability
van Zwam, P. H., Vink‐Börger, E. M., Bronkhorst, C. M., A, A. P. D. B., van der Wurff, A. A. M., Rutten, H. J. T., Lemmens, V. E. P. P., Nagtegaal, I. D., & Hugen, N. (2022) · Histopathology · doi:10.1111/his.14818 · Cited by 7
Predictive and prognostic biomarkers in gastrointestinal tract tumours
Nowak, K. M., & Chetty, R. (2024) · Pathology · doi:10.1016/j.pathol.2023.12.412 · Cited by 7
Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management
Alnakli, A., Mohamedali, A., Heng, B., Chan, C., Shin, J., Solomon, M. J., Chapuis, P. H., Guillemin, G. J., Baker, M. S., & Ahn, S. B. (2024) · BJC Reports · doi:10.1038/s44276-024-00043-z · Cited by 8
Association of Microsatellite Instability and Gene Expression Profile in Colorectal Carcinoma and Potential Implications for Therapy
Kibriya, M. G., Jasmine, F., Khamkevych, Y., Raza, M., Kamal, M., Bissonnette, M., & Ahsan, H. (2024) · Medicina · doi:10.3390/medicina60030348 · Cited by 7
The progress and challenges in modeling colorectal cancer and the impact on novel drug discovery
Teixeira, N., Baião, A., Dias, S., & Sarmento, B. F. C. C. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2404238 · Cited by 7
Advances in diagnostic and therapeutic applications of mismatch repair loss in cancer
DeWitt, J., Jimenez-Tovar, D., Mazumder, A., & Haricharan, S. (2025) · DNA Repair · doi:10.1016/j.dnarep.2025.103822 · Cited by 7
DNA mismatch repair and microsatellite instability in colorectal tumors: an observational study in the Veterans Affairs Health Care System
Waller, J., Gu, L., Hoedt, A. M. D., Freedland, S. J., Wang, T., Amonkar, M. M., Aurora-Garg, D., Liaw, K., Wehn, A. K., & Klaassen, Z. W. A. (2022) · Future Oncology · doi:10.2217/fon-2021-0874 · Cited by 7
Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Advanced Colorectal Cancer
Papke, D. J., Lindeman, N. I., Schrag, D., & Iorgulescu, J. B. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0279 · Cited by 7
IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer
Rong, Y., Xu, Y.-C., Chen, X.-C., Zhong, M., Tan, Y., Liang, Y.-F., Weng, J., Liu, J., Wang, X.-Y., Luo, D., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47739-9 · Cited by 7

Authors: Vilar, E., & Gruber, S. B.
Affiliations: University of Michigan (US)
Corresponding author: Gruber, Stephen B.
ORCID: Vilar, Eduardo
Gruber, Stephen B.
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2010-02-09
Volume: 7
Issue: 3
Pages: 153-162
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/nrclinonc.2009.237
PMC: PMC3427139
OpenAlex: W2050658928
Cited by: 1,063
References: 100
Citations by year: 2026: 57 · 2025: 100 · 2024: 116 · 2023: 114 · 2022: 99 · 2021: 81 · 2020: 75 · 2019: 65 · 2018: 66 · 2017: 46 · 2016: 34 · 2015: 47 · 2014: 44 · 2013: 44 · 2012: 28
FWCI: 4.61
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (5P30 CA 46592, 1R01CA81488, R01CA081488, P30CA046592)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords: microsatellite instability, colorectal cancer, mismatch repair deficiency, prognosis, predictive biomarkers, irinotecan, kinase mutations, targeted therapy
MeSH terms: DNA Repair, Humans, Colorectal Neoplasms, Germ-Line Mutation, DNA Repair Enzymes, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks